Silo Pharma, Inc.
USD6.13
+0.85 (+16.07%)
CEO
Eric Weisblum
IPO Date
2021-01-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.00
Prev. Close
$5.28
Day Low
$5.00
Day High
$6.26
52W Low
$3.31
52W High
$15.15
Market Cap
$0.01B
Volume
0.12M
| 2,500 |
| $0.42 |
| 21 Nov 2025 | Weisblum Eric | director, officer: Chief Executive Officer | P-Purchase | Acquired | 1,000 | $0.37 |
| 21 Nov 2025 | Weisblum Eric | director, officer: Chief Executive Officer | P-Purchase | Acquired | 1,000 | $0.36 |
| 20 Nov 2025 | Weisblum Eric | director, officer: Chief Executive Officer | P-Purchase | Acquired | 7,500 | $0.40 |
| 20 Nov 2025 | Weisblum Eric | director, officer: Chief Executive Officer | P-Purchase | Acquired | 4,500 | $0.41 |
| 28 May 2025 | Weisblum Eric | director, officer: Chief Executive Officer | P-Purchase | Acquired | 10,000 | $0.43 |
| 27 May 2025 | Linsley Wayne | director | A-Award | Acquired | 50,000 | $0.43 |
| 27 May 2025 | Munoz Kevin | director | A-Award | Acquired | 50,000 | $0.43 |
| 27 May 2025 | Ryweck Daniel E. | Chief Financial Officer | A-Award | Acquired | 50,000 | $0.43 |